Radius Health ("Radius" or "the Company"), a specialty biopharmaceutical company dedicated to bone health and related therapeutic areas, including through its lead product TYMLOS® (abaloparatide) ...

Radius' lead product, TYMLOS® (abaloparatide) injection, a parathyroid hormone related peptide, is approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women and men ...

Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical ...

Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos. The health technology assessment (HTA) agency said ...

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix) has ...

Even low doses of prednisone increase the risk for fracture, with clinically meaningful harm emerging within months rather than years. Daily doses of 2.5-7.5 mg raise the risk for fracture as early as ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Nature of the Case and Issue (s) Presented: Novo makes and sells Wegovy. Novo sued Mylan asserting patent infringement of five patents that are listed, or Novo ...